Trial Suggests Expanded Role for Blinatumomab in Treating ALL Cancer Currents: An NCI Cancer Research Blog, 25 Jan 2023 The immunotherapy drug blinatumomab (Blincyto) extends life for people with acute lymphoblastic leukemia who are in remission…